Асосий контентга ўтиш
AkademIndex

Хизматлар

← Ишга қайтиш

Ушбу иш иқтибос қилган ишлар

150 та иш

Иш: Viral modulation of angiogenesis through microRNA networks: Implications for cancer biology, biomarkers, and therapy

  1. Cell death pathways and viruses: Role of microRNAs

    Javid Sadri Nahand, Layla Shojaie, Seyed Amirreza Akhlagh +9

    Шарҳ мақола202117 иқтибос
    ABI

  2. Exosomal miRNAs: the tumor's trojan horse in selective metastasis

    Mobina Bayat, Javid Sadri Nahand

    Шарҳ мақола202416 иқтибос
    ABI

  3. MiRNA-related metastasis in oral cancer: moving and shaking

    Meghdad Eslami, Saba Khazeni, Xaniar Mohammadi Khanaghah +9

    Шарҳ мақола202314 иқтибос
    ABI

  4. Regulatory role of microRNAs in virus-mediated inflammation

    Hossein Bannazadeh Baghi, Mobina Bayat, Parisa Mehrasa +9

    Шарҳ мақола202412 иқтибос
    ABI

  5. Circular RNAs: New Epigenetic Signatures in Viral Infections

    Javid Sadri Nahand, Sogol Jamshidi, Michael R. Hamblin +7

    Шарҳ мақола202012 иқтибос
    ABI

  6. Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: A review

    Javid Sadri Nahand, Mohsen Moghoofei, Arash Salmaninejad +8

    Шарҳ мақола201910 иқтибос
    ABI

  7. The role of HPV gene expression and selected cellular MiRNAs in lung cancer development

    Bashdar Mahmud Hussen, Gelavizh Ahmadi, Havva Marzban +6

    Мақола202010 иқтибос
    ABI

  8. microRNAs: Key players in virus‐associated hepatocellular carcinoma

    Javid Sadri Nahand, Farah Bokharaei‐Salim, Arash Salmaninejad +9

    Шарҳ мақола20189 иқтибос
    ABI

  9. Exosomal MicroRNAs: Novel Players in Cervical Cancer

    Javid Sadri Nahand, Noushin Rezaei Vandchali, Hassan Darabi +6

    Шарҳ мақола20209 иқтибос
    ABI

  10. The assessment of selected MiRNAs profile in HIV, HBV, HCV, HIV/HCV, HIV/HBV Co-infection and elite controllers for determination of biomarker

    Sepehr Yousefpouran, Shayan Mostafaei, Pegah Vahidi Manesh +8

    Мақола20208 иқтибос
    ABI

  11. Exosomal miRNAs: Novel Players in Viral Infection

    Javid Sadri Nahand, Maryam Mahjoubin‐Tehran, Mohsen Moghoofei +7

    Шарҳ мақола20208 иқтибос
    ABI

  12. The association between HPV gene expression, inflammatory agents and cellular genes involved in EMT in lung cancer tissue

    Marzieh Rezaei, Shayan Mostafaei, Amir Aghaei +10

    Мақола20207 иқтибос
    ABI

  13. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

    David S. Hong, Yoon‐Koo Kang, Mitesh J. Borad +20

    Мақола20206 иқтибос
    ABI

  14. Possible role of HPV/EBV coinfection in anoikis resistance and development in prostate cancer

    Javid Sadri Nahand, Khadijeh Khanaliha, Hamed Mirzaei +6

    Мақола20215 иқтибос
    ABI

  15. The role of Epstein‐Barr virus‐expressed genes in breast cancer development

    Shayan Mostafaei, Pegah Vahidi Manesh, Javid Sadri Nahand +10

    Мақола20204 иқтибос
    ABI

  16. Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study

    Nico van Zandwijk, Nick Pavlakis, Steven Kao +14

    Мақола20173 иқтибос
    ABI

  17. MicroRNAs As Novel Regulators of Angiogenesis

    Yajaira Suárez, William C. Sessa

    Шарҳ мақола20093 иқтибос
    ABI

  18. Contribution of Angiogenesis to Inflammation and Cancer

    Dolores Aguilar‐Cázares, Rodolfo Chavez-Dominguez, Ángeles Carlos‐Reyes +3

    Шарҳ мақола20193 иқтибос
    ABI

  19. Epstein–Barr virus and thyroid cancer: The role of viral expressed proteins

    Mohsen Moghoofei, Shayan Mostafaei, Abolfazl Nesaei +6

    Мақола20183 иқтибос
    ABI

  20. Human papillomavirus and prostate cancer: The role of viral expressed proteins in the inhibition of anoikis and induction of metastasis

    Maryam Fatemipour, Javid Sadri Nahand, Maryam Ebadi Fard Azar +7

    Мақола20203 иқтибос
    ABI

  21. Real-world Outcome of Patients with Advanced Renal Cell Carcinoma and Intermediate- or Poor-risk International Metastatic Renal Cell Carcinoma Database Consortium Criteria Treated by Immune-oncology Combinations: Differential Effectiveness by Risk Group?

    Matteo Santoni, Sebastiano Buti, Zin Myint +63

    Мақола20233 иқтибос
    ABI

  22. Сарлавҳасиз

    Бошқа3 иқтибос
    ABI

  23. Сарлавҳасиз

    Бошқа3 иқтибос
    ABI

  24. Сарлавҳасиз

    Бошқа3 иқтибос
    ABI

  25. Сарлавҳасиз

    Бошқа3 иқтибос
    ABI